病毒学报

参考文献

[1]Zhu J,Ghosh A,Sarkar S N.OASL-a new player in controlling antiviral innate immunity[J].Curr Opin Virol,2015,12:15-19.

[2]Marques J,Anwar J,Eskildsen-Larsen S,Rebouillat D,Paludan S R,Sen G,Williams B R.G,Hartmann R.The p59oligoadenylate synthetase-like protein possesses antiviral activity that requires the C-terminal ubiquitinlike domain[J].J Gen Virol,2008,89(Pt 11):2767-2772.

[3]朱丹.猪源OAS抗日本脑炎病毒感染的活性研究[D].南京农业大学,2014.

[4]杨超,陈舜,汪铭书,程安春.鹅OASL基因的生物学特性初探[C].中国天津:2015.

[5]毕可然,韩凯凯,李银,刘青涛,赵冬敏,刘宇卓,黄欣梅,杨婧.樱桃谷鸭OASL基因全长cDNA的克隆及其生物信息学分析[J].江苏农业学报,2017,33(2):373-378.

[6]Bi K R,Han K K,Li Y,Liu Q T,Zhao D M,Liu Y Z,Huang X M,Yang J.Molecular cloning,characterization,and expression of duck 2′-5′-oligoadenylate synthetase-like gene[J].Gene,2017,629:43-51.

[7]Kristiansen H,Gad H H,Eskildsen-Larsen S,Despres P,Hartmann R.The oligoadenylate synthetase family:an ancient protein family with multiple antiviral activities[J].J Interferon Cytokine Res,2010,31(1):41-47.

[8]Kakuta S,Shibata S,Iwakura Y.Genomic structure of the mouse 2′,5′-oligoadenylate synthetase gene family[J].J Interferon Cytokine Res,2002,22(9):981-993.

[9]Eskildsen S,Justesen J,Schierup M H,Hartmann R.Characterization of the 2′-5′-oligoadenylate synthetase ubiquitin-like family[J].Nucleic Acids Res,2003,31(12):3166-3173.

[10]Choi U Y,Kang J S,Hwang Y S,Kim Y J.Oligoadenylate synthase-like(OASL)proteins:dual functions and associations with diseases[J/OL].Exp Mol Med,2015,47:e144.

[11]Benech P,Mory Y,Revel M,Chebath J.Structure of two forms of the interferon-induced(2′-5′)oligo A synthetase of human cells based on cDNAs and gene sequences[J].EMBO J,1985,4(9):2249-2256.

[12]Guo X C,Li X Y,Xu Y X,Sun T,Yang G,Wu Z W,Li E G.Identification of OASL d,a splice variant of human OASL,with antiviral activity[J].Int J Biochem Cell Biol,2012,44(7):1133-1138.

[13]Eskildsen S,Hartmann R,Kjeldgaard N O,Justesen J.Gene structure of the murine 2′-5′-oligoadenylate synthetase family[J].Cell Mol Life Sci,2002,59(7):1212-1222.

[14]Chakrabarti A,Jha B K,Silverman R H.New insights into the role of RNase L in innate immunity[J].J Interferon Cytokine Res,2011,31(1):49-57.

[15]Kwon Y C,Kang J I,Hwang S B,Ahn B Y.The ribonuclease L-dependent antiviral roles of human 2′,5′-oligoadenylate synthetase family members against hepatitis C virus[J].FEBS Lett,2012,587(2):156-164.

[16]Brehin A C,Casademont I,Frenkiel M P,Julier C,Sakuntabhai A,Desprès P.The large form of human2′,5′-Oligoadenylate Synthetase(OAS3)exerts antiviral effect against Chikungunya virus[J].Virology,2009,384(1):216-222.

[17]Ghosh A,Sampath P,Zhu J Z,Hornung V,Thorne S and Sarkar S N.Modulation of cellular immune response by 2′-5′Oligoadenylate Synthetase-like(OASL)proteins during DNA virus infection[J].J Immunol,2016,196(1).

[18]Peisley A,Wu B,Yao H,Walz T,Hur S.RIG-I forms signaling-competent filaments in an ATP-dependent,ubiquitin-independent manner[J].Mol Cell,2013,51(5):573-583.

[19]Zhu J,Zhang Y,Ghosh A,Cuevas R A,Forero A,Dhar J,Ibsen M S,Schmid-Burgk J L,Schmidt T,Ganapathiraju M K,Fujita T,Hartmann R,Barik S,Hornung V,Coyne C B,Sarkar S N.Antiviral activity of human OASL protein is mediated by enhancing signaling of the RIG-I RNA sensor[J].Immunity,2014,40(6):936-948.

[20]Green R,Wilkins C,Thomas S,Sekine A,Hendrick D M,Voss K,Ireton R C,Mooney M,Go J T,Choonoo G,Jeng S,de Villena F P,Ferris M T,McWeeney S,Gale M Jr.Oas1b-dependent immune transcriptional profiles of west nile virus infection in the collaborative cross[J].G3(Bethesda),2017,7(6):1665-1682.

[21]Li L F,Yu J,Zhang Y,Yang Q,Li Y,Zhang L,Wang J,Li S,Luo Y,Sun Y,Qiu H J.Interferon-inducible oligoadenylate synthetase-like protein acts as an antiviral effector against classical swine fever virus via the MDA5-mediated type I interferon-signaling pathway[J].J Virol,2017,91(11).

[22]Leisching G,Wiid I,Baker B.The Association of OASL and type i interferons in the pathogenesis and survival of intracellular replicating bacterial species[J].Front Cell Infect Microbiol.2017,7:196.

[23]Patrick K L,Bell S L,Watson R O.For Better or Worse:Cytosolic DNA Sensing during Intracellular Bacterial Infection Induces Potent Innate Immune Responses[J].J Mol Biol,2016,428(17):3372-3386.

[24]Chen Q,Sun L,Chen Z J.Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing[J].Nat Immunol,2016,17(10):1142-1149.

[25]Kim Y M,Choi W Y,Oh C M,Han G H,Kim Y J.Secondary structure of the Irf7 5′-UTR,analyzed using SHAPE(selective 2′-hydroxyl acylation analyzed by primer extension)[J].BMB Rep,2014,47(10):558-562.

[26]Lee M S,Kim B,Oh G T,Kim Y J.OASL1inhibits translation of the type I interferon-regulating transcription factor IRF7[J].Nat Immunol,2013,14(4):346-355.

[27]Ye S,Guo Q,Tang J P,Yang C D,Shen N,Chen S L.Could 2′5′-oligoadenylate synthetase isoforms be biomarkers to differentiate between disease flare and infection in lupus patients?A pilot study[J].Clin Rheumatol,2007,26(2):186-190.

[28]de Freitas A G,Oliveira D B,Botelho L M,Silva L K,Guedes A C,Santos F P,Bonjardim C A,Ferreira P C,Kroon E G.Differential upregulation of human 2′5′OAS genes on systemic sclerosis:Detection of increased basal levels of OASL and OAS2genes through aqPCR based assay[J].Autoimmunity,2014,47(2):119-126.

[29]Zhou Y,Kang M J,Jha B K,Silverman R H,Lee C G,Elias J A.Role of ribonuclease L in viral pathogenassociated molecular pattern/influenza virus and cigarette smoke-induced inflammation and remodeling[J].J Immunol,2013,191(5):2637-2646.

[30]Sanayama Y,Ikeda K,Saito Y,Kagami S,Yamagata M,Furuta S,Kashiwakuma D,Iwamoto I,Umibe T,Nawata Y,Matsumura R,Sugiyama T,Sueishi M,Hiraguri M,Nonaka K,Ohara O,Nakajima H.Prediction of therapeutic responses to tocilizumab in patients with rheumatoid arthritis:biomarkers identified by analysis of gene expression in peripheral blood mononuclear cells using genome-wide DNA microarray[J].Arthritis Rheumatol,2014,66(6):1421-1431.

[31]贾敏,王立清,陈曦,段瑾,盛艾娟,郑凤敏,王美霞,吕秋军.2′,5′-寡聚腺苷酸合成酶作为抗病毒药物乐复能的临床药效评价指标的研究[J].中国新药杂志,2014,23(20):2437-2441.

[32]郑小蔚,陈小青,章涛,李秋兰,洪文婷,林玲.特发性炎性肌病外周血干扰素诱导基因表达与临床相关性研究[J].中华风湿病学杂志,2015,19(2):81-86.

[33]Fagone P,Nunnari G,Lazzara F,Longo A,Cambria D,Distefano G,Palumbo M,Nicoletti F,Malaguarnera L,Di Rosa M.Induction of OAS gene family in HIV monocyte infected patients with high and low viral load[J].Antiviral Res,2016,131:66-73.

[34]Dhar J,Cuevas R A,Goswami R,Zhu J,Sarkar S N,Barik S.2′-5′-Oligoadenylate synthetase-like protein inhibits respiratory syncytial virus replication and is targeted by the viral nonstructural protein 1[J].J Virol,2015,89(19):10115-10119.

[35]Alcorn J F,Sarkar S N.What is the oligoadenylate synthetases-like protein and does it have therapeutic potential for influenza?[J].Expert Rev Respir Med,2015,9(1):1-3.

[36]Lin R J,Yu H P,Chang B L,Tang W C,Liao C L,Lin Y L.Distinct antiviral roles for human 2′,5′-oligoadenylate synthetase family members against dengue virus infection[J].J Immunol,2009,183(12):8035-8043.

[37]Oh J E,Lee M S,Kim Y J,Lee H K.OASL1deficiency promotes antiviral protection against genital herpes simplex virus type 2infection by enhancing type I interferon production[J].Sci Rep,2016,6:19089.

[38]Sim C K,Cho Y S,Kim B S,Baek I J,Kim Y J,Lee M S.2′-5′Oligoadenylate synthetase-like 1(OASL1)deficiency in mice promotes an effective anti-tumor immune response by enhancing the production of type I interferons[J].Cancer Immunol Immunother,2016,65(6):663-675.